Phio Pharmaceuticals Corp.
Market Cap
$14.75M
P/E Ratio
-0.88
EPS
$-1.45
Dividend Yield
0.00%
52-Week Range
$0.81 — $4.19
Volume
258.82K
Avg Volume
3.97M
Beta
0.91
P/E (TTM)
-0.88
Forward P/E
—
PEG Ratio
-4065.79
P/S (TTM)
0.00
P/B (TTM)
0.73
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.67%
ROA (TTM)
-0.40%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
49.37
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.55%
EPS Growth (5Y)
+0.60%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
-0.20%
EPS Est (This Year)
$-1.00
EPS Est (Next Year)
$-0.62
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.81
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
10.76M
Float
9.52M
Free Float %
88.43%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2012-05-10
Employees
5
CEO
Robert J. Bitterman
Index Membership
—
Website
https://www.phiopharma.com
Phio Pharmaceuticals Corp. (PHIO) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $14.75M, a P/E ratio of -0.88, PHIO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PHIO against other stocks using dozens of fundamental and technical filters.
Phio Pharmaceuticals Corp. (PHIO) has a trailing twelve-month (TTM) P/E ratio of -0.88. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Phio Pharmaceuticals Corp. (PHIO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Phio Pharmaceuticals Corp. (PHIO) has a market capitalization of $14.75 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.